Speaker illustration

Miss Maria Josefa Sanchez

Vega Baja Hospital in Orihuela, Orihuela (Spain)

Usefulness of red cell distribution width for predicting type of death in patients with acute coronary syndrome

Event: Acute Cardiovascular Care 2016

Topic: Biomarkers

Session: Biomarkers

Thumbnail

Prolonged hospital stay in patients with acute coronary syndrome: prevalence and clinical determinants.

Event: Acute Cardiovascular Care 2016

Topic: General intensive care

Session: General intensive care

Thumbnail

Usefulness of GRACE and CRUSADE risk scores in patients with chronic obstructive pulmonary disease and acute coronary syndrome.

Event: Acute Cardiovascular Care 2016

Topic: Risk Stratification

Session: Risk Stratification

Thumbnail

Acutely decompensated heart failure readmission at 1-year in patients with acute coronary syndrome.

Event: Acute Cardiovascular Care 2016

Topic: Acute Heart Failure

Session: Moderated Posters Session 3: Heart failure, nursing, special poulations

Thumbnail

Influence of diabetes status on prescription of antiplatelet therapy in patients with acute coronary syndrome.

Event: Acute Cardiovascular Care 2016

Topic: Population studies / Epidemiology

Session: Special population: diabetes, elderly and renal failure

Thumbnail

In-hospital heart failure in a contemporary cohort of patients admitted for acute coronary syndrome: incidence and clinical determinants

Event: Acute Cardiovascular Care 2016

Topic: Acute Heart Failure

Session: Acute heart failure

Thumbnail

Additional prognostic value of red cell distribution width on independent hemoglobin anemic state in patients with acute coronary syndrome.

Event: Acute Cardiovascular Care 2016

Topic: Biomarkers

Session: Biomarkers

Thumbnail

Influence of bleeding and ischemic risk on the prescription of new antiplatelets in patients with acute coronary syndrome

Event: Acute Cardiovascular Care 2016

Topic: Antithrombotic agents

Session: Antithrombotic therapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb